1. Home
  2. BHST vs OBIO Comparison

BHST vs OBIO Comparison

Compare BHST & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BHST
  • OBIO
  • Stock Information
  • Founded
  • BHST 2007
  • OBIO 2017
  • Country
  • BHST Canada
  • OBIO United States
  • Employees
  • BHST N/A
  • OBIO N/A
  • Industry
  • BHST
  • OBIO Medicinal Chemicals and Botanical Products
  • Sector
  • BHST
  • OBIO Health Care
  • Exchange
  • BHST Nasdaq
  • OBIO Nasdaq
  • Market Cap
  • BHST 136.9M
  • OBIO 118.8M
  • IPO Year
  • BHST N/A
  • OBIO N/A
  • Fundamental
  • Price
  • BHST $9.32
  • OBIO $2.57
  • Analyst Decision
  • BHST Strong Buy
  • OBIO Strong Buy
  • Analyst Count
  • BHST 2
  • OBIO 4
  • Target Price
  • BHST $13.00
  • OBIO $14.00
  • AVG Volume (30 Days)
  • BHST 19.0K
  • OBIO 403.6K
  • Earning Date
  • BHST 08-11-2025
  • OBIO 08-12-2025
  • Dividend Yield
  • BHST N/A
  • OBIO N/A
  • EPS Growth
  • BHST N/A
  • OBIO N/A
  • EPS
  • BHST N/A
  • OBIO N/A
  • Revenue
  • BHST $30,192,000.00
  • OBIO $2,944,000.00
  • Revenue This Year
  • BHST $116.40
  • OBIO $20.47
  • Revenue Next Year
  • BHST $55.91
  • OBIO $11.45
  • P/E Ratio
  • BHST N/A
  • OBIO N/A
  • Revenue Growth
  • BHST 57.83
  • OBIO 41.61
  • 52 Week Low
  • BHST $4.66
  • OBIO $2.37
  • 52 Week High
  • BHST $9.90
  • OBIO $7.04
  • Technical
  • Relative Strength Index (RSI)
  • BHST N/A
  • OBIO 40.46
  • Support Level
  • BHST N/A
  • OBIO $2.50
  • Resistance Level
  • BHST N/A
  • OBIO $2.75
  • Average True Range (ATR)
  • BHST 0.00
  • OBIO 0.18
  • MACD
  • BHST 0.00
  • OBIO -0.03
  • Stochastic Oscillator
  • BHST 0.00
  • OBIO 11.47

About BHST BioHarvest Sciences Inc. Common Stock

BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.

About OBIO Orchestra BioMed Holdings Inc.

Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.

Share on Social Networks: